The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
Oral amoxicillin and amoxicillin–clavulanic acid: properties, indications and usage
Open accessAbstract
BACKGROUND Amoxicillin has been in use since the 1970s; it is the most widely used penicillin both alone and in combination with the beta-lactamase clavulanic acid. OBJECTIVES In this narrative review, we re-examine the properties of oral amoxicillin and clavulanic acid and provide guidance on their use, with emphasis on the preferred use of amoxicillin alone. SOURCES Published medical literature (MEDLINE database via Pubmed) CONTENT: While amoxicillin and clavulanic acid have similar half-lives, clavulanic acid is more protein-bound and even less heat-stable than amoxicillin, with primarily hepatic metabolism. It is also more strongly associated with gastrointestinal side effects, including Clostridium difficile infection, and thus, in oral combination formulations, limits the maximum daily dose of amoxicillin that can be given. The first ratio for an amoxicillin-clavulanic acid combination was set at 4:1 due to clavulanic acid's high affinity for beta-lactamases; ratios of 2:1, 7:1, 14:1 and 16:1 are currently available in various regions. Comparative effectiveness data for the different ratios are scarce. Amoxicillin-clavulanic acid is often used as empiric therapy for many of the World Health Organisation's Priority Infectious Syndromes in adults and children, leading to extensive consumption, when some of these syndromes could be handled with a delayed-antibiotic-prescription approach or amoxicillin alone. IMPLICATIONS Using available epidemiologic and pharmacokinetic data, we provide guidance on indications for amoxicillin versus amoxicillin-clavulanic acid and on optimal oral administration, including choice of combination ratio. More data are needed, particularly on heat stability, pharmacodynamic effects and emergence of resistance in "real-world" clinical settings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults
Jain, S., Self, W. H., Wunderink, R. G., Fakhran, S., Balk, R., Bramley, A. M., Reed, C., Grijalva, C. G., Anderson, E. J., Courtney, D. M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500245 · Cited by 2,323
Ambler, R. P. (1980) · Philosophical Transactions of the Royal Society of London. B, Biological Sciences · doi:10.1098/rstb.1980.0049 · Cited by 1,823
Coagulase-Negative Staphylococci
Becker, K., Heilmann, C., & Peters, G. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00109-13 · Cited by 1,628
Surgical site infections: epidemiology, microbiology and prevention
Owens, C. D., & Stoessel, K. (2008) · Journal of Hospital Infection · doi:10.1016/s0195-6701(08)60017-1 · Cited by 987
Clavulanic Acid: a Beta-Lactamase-Inhibiting Beta-Lactam from Streptomyces clavuligerus
Reading, C., & Cole, M. (1977) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.11.5.852 · Cited by 739
Risk factors for Clostridium difficile infection
Bignardi, G. E. (1998) · Journal of Hospital Infection · doi:10.1016/s0195-6701(98)90019-6 · Cited by 647
Bacterial Infection in Chronic Obstructive Pulmonary Disease in 2000: a State-of-the-Art Review
Sethi, S., & Murphy, T. F. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.2.336-363.2001 · Cited by 595
Shane, A. L., Mody, R. K., Crump, J. A., Tarr, P. I., Steiner, T. S., Kotloff, K., Langley, J. M., Wanke, C., Warren, C. A., Cheng, A. C., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix959 · Cited by 532
Ki, V., & Rotstein, C. (2008) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2008/846453 · Cited by 506
Mechanisms of antimicrobial resistance in Gram-negative bacilli
Ruppé, É., Woerther, P.-L., & Barbier, F. (2015) · Annals of Intensive Care · doi:10.1186/s13613-015-0061-0 · Cited by 490
Jacobs, M. R. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg321 · Cited by 467
Jaurin, B., & Grundström, T. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.8.4897 · Cited by 390
Antibiotic penetration into bone and joints: An updated review
Thabit, A. K., Fatani, D. F., Bamakhrama, M. S., Barnawi, O. A., Basudan, L. O., & Alhejaili, S. F. (2019) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2019.02.005 · Cited by 368
Classifying antibiotics in the WHO essential medicines list for optimal use—be AWaRe
Sharland, M., Pulcini, C., Harbarth, S., Zeng, M., Gandra, S., Mathur, S., & Magrini, N. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(17)30724-7 · Cited by 336
Antianaerobic Antimicrobials: Spectrum and Susceptibility Testing
Brook, I., Wexler, H. M., & Goldstein, E. J. C. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00086-12 · Cited by 333
Uranga, A., España, P. P., Bilbao, A., Quintana, J. M., Arriaga, I., Intxausti, M., Lobo, J. L., Tomás, L., Camino, J., Nuñez, J., et al. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.3633 · Cited by 290
Nagy, E., Urbán, E., & Nord, C. E. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03256.x · Cited by 277
Revised Ambler classification of β-lactamases
Hall, B. G., & Barlow, M. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki130 · Cited by 270
Ouellette, M., Bissonnette, L., & Roy, P. H. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7378 · Cited by 238
Huttner, A., Kowalczyk, A., Turjeman, A., Babich, T., Brossier, C., Eliakim-Raz, N., Kosiek, K., Martinez de Tejada, B., Roux, X., Shiber, S., et al. (2018) · JAMA · doi:10.1001/jama.2018.3627 · Cited by 214
Self-citationClassifying antibiotics in the WHO Essential Medicines List for optimal use-be AWaRe
Sharland, M., Pulcini, C., Harbarth, S., Zeng, M., Gandra, S., Mathur, S., & Magrini, N. (2018) · Archive ouverte UNIGE (University of Geneva) · Cited by 211
Sabir, S., Anjum, A. A., Ijaz, T., Ali, M. A., Rehman, M. U., & Nawaz, M. (2014) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.302.4289 · Cited by 199
Amoxycillin: A new Semi-synthetic Penicillin
Sutherland, R., Croydon, E. A. P., & Rolinson, G. N. (1972) · BMJ · doi:10.1136/bmj.3.5817.13 · Cited by 178
Gajdács, M., Spengler, G., & Urbán, E. (2017) · Antibiotics · doi:10.3390/antibiotics6040025 · Cited by 169
Brook, I. (2011) · Proceedings of the American Thoracic Society · doi:10.1513/pats.201006-038rn · Cited by 164
Akanbi, O. E., Njom, H. A., Fri, J., Otigbu, A. C., & Clarke, A. M. (2017) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph14091001 · Cited by 161
Pharmacokinetics of Antibacterial Agents in the CSF of Children and Adolescents
Sullins, A. K., & Abdel‐Rahman, S. M. (2013) · Pediatric Drugs · doi:10.1007/s40272-013-0017-5 · Cited by 152
Onwubiko, N., & Sadiq, N. (2011) · Pan African Medical Journal · doi:10.4314/pamj.v8i1.71050 · Cited by 147
Otitis media: diagnosis and treatment.
Harmes, K. M., Blackwood, R. A., Burrows, H. L., et al. (2013) · PubMed · Cited by 143
Salvo, F., Polimeni, G., Moretti, U., Conforti, A., Leone, R., Leoni, O., Motola, D., Dusi, G., & Caputi, A. P. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm111 · Cited by 132
Spyker, D. A., Rugloski, R. J., Vann, R. L., et al. (1977) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.11.1.132 · Cited by 130
A review of the antimicrobial activity of clavulanate
Finlay, J. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg286 · Cited by 129
Detection of resistance genes and susceptibility patterns in Bacteroides and Parabacteroides strains
Boente, R. F., Ferreira, L. Q., Falcão, L. S., Miranda, K. R., Guimarães, P. L. D. S., dos Santos-Filho, J., Vieira, J. M. B. D., Barroso, D. E., Émond, J.-P., Ferreira, E. D. O., et al. (2010) · Anaerobe · doi:10.1016/j.anaerobe.2010.02.003 · Cited by 102
Determinants of the activity of -lactamase inhibitor combinations
Livermore, D. M. (1993) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/31.suppl_a.9 · Cited by 98
Wang, J., Chen, P., Chang, S., Shiau, Y., Wang, H., Lai, J., Huang, I., Tan, M.-C., & Lauderdale, T.-L. Y. (2014) · BMC Infectious Diseases · doi:10.1186/1471-2334-14-486 · Cited by 92
Etiology of Cellulitis and Clinical Prediction of Streptococcal Disease: A Prospective Study
Bruun, T., Oppegaard, O., Kittang, B. R., Mylvaganam, H., Langeland, N., & Skrede, S. (2015) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofv181 · Cited by 89
Langendorf, C., Le Hello, S., Moumouni, A., Gouali, M., Mamaty, A.-A., Grais, R. F., Weill, F.-X., & Page, A.-L. (2015) · PLOS ONE · doi:10.1371/journal.pone.0120275 · Cited by 88
Amoxicillin: In Vitro and Pharmacological Studies
Bodey, G. P., & Nance, J. (1972) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.1.4.358 · Cited by 78
Diphtheria outbreak with high mortality in northeastern Nigeria
BESA, N. C., Coldiron, M. E., BAKRI, A., RAJI, A., Nsuami, M. J., Rousseau, C., HURTADO, N., & Porten, K. (2013) · Epidemiology and Infection · doi:10.1017/s0950268813001696 · Cited by 77
Naimi, H. M., Rasekh, H., Noori, A. Z., & Bahaduri, M. A. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2844-4 · Cited by 76
Falagas, M. E., Karageorgopoulos, D. E., Grammatikos, A. P., & Matthaiou, D. K. (2008) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2008.03306.x · Cited by 75
Shiferaw, B., Solghan, S. M., Palmer, A., Joyce, K. W., Barzilay, E. J., Krueger, A. L., & Cieslak, P. R. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis230 · Cited by 75
Weitschies, W., Friedrich, C., Wedemeyer, R., Schmidtmann, M., Kosch, O., Kinzig, M., Trahms, L., Sörgel, F., Siegmund, W., Horkovics-Kovats, S., et al. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.05.011 · Cited by 72
Carlier, M., Noe, M., Waele, J. J. D., Stove, V. V., Verstraete, A., Lipman, J., & Roberts, J. A. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt240 · Cited by 69
Antibiotic Resistance of Campylobacter Species in a Pediatric Cohort Study
Schiaffino, F., Colston, J. M., Olórtegui, M. P., François, R., Pisanic, N., Burga, R., Yori, P. P., & Kosek, M. N. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01911-18 · Cited by 67
IntegratingEscherichia coliAntimicrobial Susceptibility Data from Multiple Surveillance Programs
Stelling, J. M., Travers, K. U., Jones, R. N., et al. (2005) · Emerging infectious diseases · doi:10.3201/eid1106.041160 · Cited by 65
Hussen, S., Mulatu, G., & Kassa, Z. Y. (2019) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-019-0321-1 · Cited by 61
Singh, A. K., Das, S., Singh, S., Gajamer, V. R., Pradhan, N., Lepcha, Y. D., & Tiwari, H. K. (2018) · PLoS ONE · doi:10.1371/journal.pone.0199179 · Cited by 60
Antimicrobial resistance among Brazilian Corynebacterium diphtheriae strains
Pereira, G. A., Pimenta, F. P., dos Santos, F. R. W., Damasco, P. V., Hirata, R., & Mattos‐Guaraldi, A. L. (2008) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762008000500019 · Cited by 55
Treatment of complicated intra-abdominal infections in the era of multi-drug resistant Bacteria
Herzog, T., Chromik, A., & Uhl, W. (2010) · European journal of medical research · doi:10.1186/2047-783x-15-12-525 · Cited by 53
Emergence of carbapenem resistance in Bacteroides fragilis in China
Gao, Q., Wu, S., Xu, T., Zhao, X., Huang, H., & Hu, F. (2019) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2019.02.017 · Cited by 53
Soriano, F. G., Granizo, J. J., Coronel, P., et al. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2003.07.018 · Cited by 52
Zhang, S.-X., Zhou, Y., Tian, L.-G., Chen, J., Torres, R. T., Serrano, E., Li, S., Chen, S., Ai, L., Chen, J., et al. (2018) · Infectious Diseases of Poverty · doi:10.1186/s40249-018-0427-2 · Cited by 48
Tansarli, G. S., Athanasiou, S., & Falagas, M. E. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00359-13 · Cited by 47
Könönen, E., Kanervo, A., Salminen, K. R., & Jousimies-Somer, H. R. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.5.1270 · Cited by 46
de Miranda, É. J. P., de Oliveira, G. S. S., Roque, F. L., dos Santos, S. R., Olmos, R. D., & Lotufo, P. A. (2014) · Revista do Instituto de Medicina Tropical de São Paulo · doi:10.1590/s0036-46652014000400009 · Cited by 36
Guyomard-Rabenirina, S., Malespine, J., Ducat, C., Sadikalay, S., Falord, M., Harrois, D., Richard, V., Dozois, C. M., Breurec, S., & Talarmin, A. (2016) · BMC Microbiology · doi:10.1186/s12866-016-0749-9 · Cited by 33
Brandon, M., & Dowzicky, M. J. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.00157-13 · Cited by 32
Erb, S., Frei, R., Tschudin‐Sutter, S., et al. (2018) · Swiss Medical Weekly · doi:10.4414/smw.2018.14660 · Cited by 31
Aldman, M. H., Skovby, A., & Påhlman, L. I. (2017) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2017.1280617 · Cited by 25
Highly variable absorption of clavulanic acid during the day: a population pharmacokinetic analysis
de Velde, F., de Winter, B. C. M., Koch, B. C. P., van Gelder, T., & Mouton, J. W. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx376 · Cited by 25
Self-citationSusceptibility testing with clavulanic acid: fixed concentration versus fixed ratio
Thomson, C. J., Miles, R. S., & Amyes, S. G. B. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2591 · Cited by 21
Horner, C., Abberley, N., Denton, M., & Wilcox, M. H. (2013) · Epidemiology and Infection · doi:10.1017/s0950268813000988 · Cited by 20
Toledo, Z., Simaluiza, R. J., Romero, X. A., & Heriberto Fernández, J. (2017) · Revista do Instituto de Medicina Tropical de São Paulo · doi:10.1590/s1678-9946201759077 · Cited by 19
(2012) · Cited by 18
Stability of amoxycillin and potassium clavulanate in co-amoxiclav oral suspension
Mehta, A. C., Hart–Davies, S., Paynet, J., & LACEY, R. W. (1994) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.1994.tb00818.x · Cited by 16
Bamford, C., Bonorchis, K., Ryan, A., Hoffmann, R., Naicker, P. R., Maloba, M. R. B., Nana, T., Zietsman, I. L., & Govind, C. (2012) · Southern African Journal of Epidemiology and Infection · doi:10.1080/10158782.2012.11441483 · Cited by 15
THE STABILITY OF AMOXYCILLIN SODIUM IN INTRAVENOUS INFUSION FLUIDS
Cook, B., Hill, S. A., & Lynn, B. (1982) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.1982.tb01029.x · Cited by 15
Westh, H., Møller, J. K., & Gutschik, E. (1991) · Infection · doi:10.1007/bf01643244 · Cited by 13
Cited by
Rosmarinic acid–Modes of antimicrobial and antibiofilm activities of a common plant polyphenol
Ivanov, M., Kostić, M., Stojković, D., & Soković, M. (2022) · South African Journal of Botany · doi:10.1016/j.sajb.2021.11.050 · Cited by 98
MATTINA, R., & SCAGLIONE, F. (2025) · Minerva Medica · doi:10.23736/s0026-4806.25.09808-8 · Cited by 1
Metadata
- Authors
- Huttner, A., Bielicki, J., Clements, M. N., Frimodt-Møller, N., Muller, A. E., Paccaud, J.-P., & Mouton, J. W.
- Venue
- Clinical Microbiology and Infection
- Publisher
- Elsevier BV
- Published
- 2020-07
- Volume
- 26
- Issue
- 7
- Pages
- 871-879
- ISSN
- 1198-743X (ISSN-L)
- OpenAlex
- W2991735893
- Cited by
- 270
- References
- 69
- FWCI
- 8.36
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.